Bristol-Myers Squibb Holdings Limited
Activities of head offices · Denham
ActiveUnited KingdomIncorporated 1932Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
—
Cash
—
Turnover
—
Profit / loss
—
Current assets
—
Creditors < 1 year
—
Equity
£100,000
Average employees
Not available
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Equity | £100,000 | £100,000 |
| Share capital | £100,000 | £100,000 |
| Assets | ||
| Fixed assets | £100,000 | £100,000 |
| Debtors | £100,000 | £100,000 |
| Operating costs | ||
| Audit fees | £6,000 | £6,000 |
| People & pay | ||
| Directors' remuneration | £0 | £0 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- Deloitte LLP
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Bristol-Myers Squibb Pharmaceuticals International Holdings Netherlands B.V.
- Ultimate parent
- Bristol-Myers Squibb Company
- Ultimate controlling party
- Bristol-Myers Squibb Company
- Accounts
- FRS 102
- Approved
- 2026-06-08, signed by A Ong
Subsidiaries (1)
- E.R. Squibb & Sons Limited · 100% · England; ARC Uxbridge, Sanderson Road, New Denham, Denham, Buckinghamshire, UB8 1DH
Share classes (1)
- 100 Ordinary shares of £1 each of £1
Events after the year end (1)
- There are no events to report after the statement of financial position date.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.